Etomidate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Etomidate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Oct 5, 2022.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-6695-02
- Dosage Form
- Injection
- Presentation
- Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)
- Initial Posting
- Oct 5, 2022